Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 30, 2014 08:30 ET | Source: Aastrom Biosciences, Inc.

Aastrom Biosciences Added to Russell Microcap Index

ANN ARBOR, Mich., June 30, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases...
June 24, 2014 08:45 ET | Source: Aastrom Biosciences, Inc.

Aastrom Announces Initiation of Commercial Sales of Bone Marrow by Marrow Donation, LLC

ANN ARBOR, Mich., June 24, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases...
June 16, 2014 06:00 ET | Source: Aastrom Biosciences, Inc.

Aastrom Announces Strategic Plan for Recently Acquired Cell Therapy and Regenerative Medicine Business

Manufacturing of MACI in Denmark to be discontinued Sales of MACI in Europe, representing 1% of revenues in 2014, temporarily ceased U.S. action plan implemented to optimize R&D,...
June 15, 2014 18:00 ET | Source: Aastrom Biosciences, Inc.

Aastrom Announces Investor Conference Call and Webcast June 16, 2014 at 8:30 AM EDT

ANN ARBOR, Mich., June 15, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases...
June 04, 2014 08:45 ET | Source: Aastrom Biosciences, Inc.

Aastrom Announces Appointment of Gerard Michel as Chief Financial Officer and Vice President, Corporate Development

ANN ARBOR, Mich., June 4, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases...
June 02, 2014 08:45 ET | Source: Aastrom Biosciences, Inc.

Aastrom Completes Acquisition of Sanofi's Cell Therapy and Regenerative Medicine Business

ANN ARBOR, Mich., June 2, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases...
May 15, 2014 16:05 ET | Source: Aastrom Biosciences, Inc.

Aastrom Biosciences Reports First-Quarter 2014 Financial Results

ANN ARBOR, Mich., May 15, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe,...
May 09, 2014 16:05 ET | Source: Aastrom Biosciences, Inc.

Aastrom Biosciences to Host First Quarter 2014 Investor Call on May 15, 2014

ANN ARBOR, Mich., May 9, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded multicellular therapies for the treatment of severe...
May 02, 2014 16:05 ET | Source: Aastrom Biosciences, Inc.

Aastrom to Hold Annual Meeting of Shareholders on May 7, 2014

ANN ARBOR, Mich., May 2, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe,...
April 21, 2014 08:30 ET | Source: Aastrom Biosciences, Inc.

Aastrom Announces Definitive Agreement to Acquire Sanofi's Cell Therapy and Regenerative Medicine Business

ANN ARBOR, Mich., April 21, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe,...